ArticleJournal of ophthalmic & vision research2025

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.

Diego Dominguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.